Skip to content

Research of immune function in preterm bronchopulmonary dysplasia

Research of immune function in preterm bronchopulmonary dysplasia

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200057615
Enrollment
Unknown
Registered
2022-03-15
Start date
2022-03-01
Completion date
Unknown
Last updated
2023-10-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bronchopulmonary dysplasia

Interventions

control group:
BPD group:

Sponsors

Department of Neonatal Pediatrics, Department of Pediatrics, the Seventh Medical Center of PLA General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Premature infants, who were still given oxygen 28 days after birth, as the BPD group, collect blood and bronchoalveolar lavage fluid; 2. Blood of healthy preterm infants was collected as control group 1, and bronchoalveolar lavage fluid of non-BPD children using invasive ventilator was collected as control group 2.

Exclusion criteria

Exclusion criteria: The subjects who were congenital anomalies, hemopathy or suffered sepsis during the immune function detecting period were excluded.

Design outcomes

Primary

MeasureTime frame
Cellular immune examination;Human leukocyte antigen, HLA;cytokine;

Secondary

MeasureTime frame
Cytotoxic T-Lymphocyte Antigen 4, CTLA4;

Countries

China

Contacts

Public ContactJieting Huang

Department of Neonatal Pediatrics, Department of Pediatrics, the Seventh Medical Center of PLA General Hospital

cdefab@163.com+86 10 84008773

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026